Richter signs exclusive distribution contract for cancer pain drug in CIS, Bulgaria and Romania
Hungarian drug company Richter announced on Tuesday it had signed an agreement with Orexo to be the exclusive distributor of the Swedish pharma company's drug Rapinyl, used to treat pain in cancer patients, in the CIS, Bulgaria and Romania.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.